7Baggers
 Published on: 2025-10-03 01:15:11  newser.com Fri, 03 Oct 2025 06:15:11 GMT
 published on: 2025-09-29 03:27:23  newser.com Mon, 29 Sep 2025 08:27:23 GMT
 Published on: 2025-09-27 15:26:00  newser.com Sat, 27 Sep 2025 20:26:00 GMT
 laser photonics corporation stock analysis and forecast  Early Times Sat, 27 Sep 2025 03:29:45 GMT
 Janux Therapeutics stock hits 52-week low at 21.97 USD By Investing.com  Investing.com South Africa Fri, 26 Sep 2025 01:20:12 GMT
 Janux Therapeutics stock hits 52-week low at 21.97 USD  Investing.com Thu, 25 Sep 2025 20:13:30 GMT
 AbbVie (ABBV) Gets a Buy from Leerink Partners  The Globe and Mail Thu, 25 Sep 2025 14:38:00 GMT
 Top 5 Oncology Stocks to Watch According to Barclays By Investing.com  Investing.com Nigeria Mon, 22 Sep 2025 07:00:00 GMT
 janux therapeutics (nasdaq:janx) shares gap up - time to buy?  MarketBeat Mon, 22 Sep 2025 05:07:07 GMT
 janux therapeutics (nasdaq:janx) shares gap up - time to buy?  MarketBeat Sun, 21 Sep 2025 07:00:00 GMT
 janux therapeutics (nasdaq:janx) shares gap up - should you buy?  MarketBeat Sun, 21 Sep 2025 04:10:14 GMT
 barclays begins coverage on janux therapeutics (nasdaq:janx)  MarketBeat Sun, 21 Sep 2025 04:00:17 GMT
 janux therapeutics announces departure of chief strategy officer  The Globe and Mail Sat, 20 Sep 2025 21:34:00 GMT
 Janux Therapeutics resumed with a Buy at Stifel  MSN Sat, 20 Sep 2025 14:28:09 GMT
 janux therapeutics chief strategy officer departs in company-initiated move  Investing.com India Sat, 20 Sep 2025 00:51:00 GMT
 janux therapeutics (nasdaq:janx) now covered by barclays  MarketBeat Fri, 19 Sep 2025 11:22:16 GMT
 barclays initiates coverage on janux therapeutics (nasdaq:janx)  MarketBeat Fri, 19 Sep 2025 11:22:16 GMT
 piper sandler initiates coverage of oncology companies  MSN Fri, 19 Sep 2025 01:25:30 GMT
 barclays initiates coverage on janux therapeutics (nasdaq:janx)  MarketBeat Thu, 18 Sep 2025 12:27:52 GMT
 janux therapeutics (nasdaq:janx) now covered by barclays  MarketBeat Thu, 18 Sep 2025 12:27:52 GMT
 Barclays Initiates Coverage on JANX with Overweight Rating | JAN  GuruFocus Wed, 17 Sep 2025 12:11:16 GMT
 Janux Therapeutics initiated with an Overweight at Barclays  TipRanks Tue, 16 Sep 2025 07:00:00 GMT
 10 best up and coming stocks with huge upside potential  Insider Monkey Sun, 14 Sep 2025 07:00:00 GMT
 janux therapeutics (nasdaq:janx) now covered by truist financial  MarketBeat Fri, 12 Sep 2025 13:41:17 GMT
 Bank of America Securities Remains a Buy on Janux Therapeutics Inc (JANX)  The Globe and Mail Fri, 12 Sep 2025 07:00:00 GMT
 janux is a new buy at truist ahead of catalyst rich h2  MSN Thu, 11 Sep 2025 15:17:42 GMT
 janux therapeutics (nasdaq:janx) now covered by guggenheim  MarketBeat Thu, 11 Sep 2025 08:55:29 GMT
 janux therapeutics (nasdaq:janx) coverage initiated at guggenheim  MarketBeat Thu, 11 Sep 2025 07:00:00 GMT
 stifel resumes janux therapeutics stock coverage with buy rating by investing.com  Investing.com Nigeria Thu, 11 Sep 2025 06:50:49 GMT
 Janux is a new Buy at Truist ahead of catalyst rich H2  MSN Wed, 10 Sep 2025 19:03:07 GMT
 Truist Securities initiates Janux Therapeutics stock with Buy rating  Investing.com Wed, 10 Sep 2025 07:00:00 GMT
 Stifel resumes Janux Therapeutics stock coverage with Buy rating  Investing.com Wed, 10 Sep 2025 07:00:00 GMT
 Janux stock a new Buy at Truist on H2 catalysts (JANX:NASDAQ)  Seeking Alpha Wed, 10 Sep 2025 07:00:00 GMT
 Truist Initiates Janux Therapeutics at Buy With $100 Price Target  MarketScreener Wed, 10 Sep 2025 07:00:00 GMT
 janux therapeutics resumed with a buy at stifel  TipRanks Wed, 10 Sep 2025 07:00:00 GMT
 janux therapeutics initiated with a buy at truist  TipRanks Wed, 10 Sep 2025 07:00:00 GMT
 analysts set janux therapeutics, inc. (nasdaq:janx) pt at $86.90  MarketBeat Tue, 09 Sep 2025 07:00:00 GMT
 janux therapeutics (nasdaq:janx) coverage initiated at guggenheim  MarketBeat Mon, 08 Sep 2025 11:38:14 GMT
 janux therapeutics initiated with a buy at guggenheim  TipRanks Thu, 04 Sep 2025 09:57:42 GMT
 guggenheim initiates janux therapeutics at buy with $72 price target  MarketScreener Thu, 04 Sep 2025 07:00:00 GMT
 published on: 2025-09-02 13:17:12  Newser Tue, 02 Sep 2025 18:17:12 GMT
 published on: 2025-09-02 07:17:26  Newser Tue, 02 Sep 2025 12:17:26 GMT
 published on: 2025-09-02 03:50:49  Newser Tue, 02 Sep 2025 08:50:49 GMT
 published on: 2025-09-01 15:48:42  Newser Mon, 01 Sep 2025 20:48:42 GMT
 published on: 2025-08-30 22:53:15  Newser Sun, 31 Aug 2025 03:53:15 GMT
 published on: 2025-08-30 20:43:08  Newser Sun, 31 Aug 2025 01:43:08 GMT

Janux Therapeutics
(NASDAQ:JANX) 

JANX stock logo

Janux Therapeutics is an innovative clinical-stage biopharmaceutical company developing next-generation therapeutics based on applying its proprietary technology to its Tumor Activated T Cell Engager (TRACTr) and Tumor Activated Immunomodulator (TRACIr) platforms to better treat patients suffering f...

Founded: 2017
IPO Price: $17 (Jun 11, 2021)
CEO: David Campbell  
Sector:
Industry:

Share this website to your friends